The NeuroPOCT-preTBI-pilot study is a prospective prehospital study evaluating point-of-care measurement of the brain injury biomarkers GFAP and UCH-L1 in adults with suspected mild traumatic brain injury.
The study investigates the feasibility and diagnostic performance of measuring these biomarkers directly in the ambulance using the i-STAT Alinity TBI cartridge, with the aim of identifying patients with acute traumatic intracranial lesions. The results will help inform future studies investigating whether biomarker-guided strategies could support safer and more individualized prehospital management of patients with mild head injury.Â
Biomarker results are collected for research purposes only and do not influence clinical assessment, treatment, triage, or transport decisions.
This site provides information for patients, ambulance personnel, and healthcare professionals involved in or interested in the study.